MATERIAL SAFETY DATA SHEET
SECTION 1 - IDENTIFICATION OF PRODUCT AND COMPANY
1-866-531-8896
Pfizer Inc Emergency telephone
24 Hours
Pfizer Animal Health Hours of operation
1-800-366-5288
235 East 42nd Street Telephone
New York, NY 10017
Trade names Oti-Clens庐
Product name Oti-Clens庐
Veterinary ear cleansing agent
Therapeutic use
Clear, colorless liquid with menthol/citronella fragrance
Description
SECTION 2 - COMPOSITION
Ingredient CAS Number Amount
Malic acid* 6915-15-7 <5.0%
Benzoic Acid* 65-85-0 <1.0%
Salicylic Acid* 69-72-2 <1.0%
Propylene glycol 57-55-6 <50%
Trade Secret Trade Secret >55%
*Hazardous
Note: Ingredient(s) indicated as hazardous have been assessed under standards
for workplace safety.
SECTION 3 - HAZARDS IDENTIFICATION
Signal word CAUTION!
Statements of hazard MAY CAUSE EYE AND SKIN IRRITATION.
May cause eye irritation.
Eye effects
May cause skin irritation.
Skin effects
Inhalation effects None known, An Occupational Exposure Limit has been established for
one or more of the ingredients (see Section 8).
Ingestion effects Toxicity following ingestion is not expected. Ingestion should be avoided.
This document has been prepared in accordance with standards for
NOTE:
workplace safety, which require the inclusion of all known hazards of the
product or its ingredients regardless of the potential risk. The
precautionary statements and warnings included may not apply in all
cases. Your needs may vary depending upon the potential for exposure in
your workplace.
10000449 - Oti-Clens庐 Pfizer Inc.
Revision date: 02/03/94, Version: 1.0.0 Page 1 of 5
SECTION 4 - FIRST AID MEASURES
Wash hands and arms thoroughly after handling this material. Obtain
Skin
medical assistance if skin effects occur.
Eyes Immediately flush eyes with water for at least 15 minutes. If irritation
occurs or persists, get medical attention.
Inhalation Remove to fresh air. If discomfort persists, get medical attention.
In the event of swallowing this material, seek immediate medical attention.
Ingestion
SECTION 5 - FIRE FIGHTING MEASURES
This mixture is non-flammable.
General hazard
Wear approved positive pressure, self-contained breathing apparatus and
Fire fighting instructions
full protective turn out gear. Move containers from fire area if possible
without increased personal risk. Dike area if possible to contain water for
later disposal.
Use carbon dioxide, dry chemical, or water spray.
Extinguishing media
Non-flammable
Flash point
Toxic or corrosive gases are expected in fires involving this mixture.
Hazardous combustion
products
SECTION 6 - ACCIDENTAL RELEASE MEASURES
Review Sections 3, 8 and 12 before proceeding with clean up.
General
Use non-combustible material to absorb spill; then place in a suitable,
Small spill
labeled recovery container. Clean spill area thoroughly. Prevent discharge
to drains.
Large spill Contain the source of the spill or leak if it is safe to do so. Collect wash
water with a non-combustible absorbant material and transfer to labeled
container for treatment and disposal. Clean spill area thoroughly. Prevent
discharge to drains.
SECTION 7 - HANDLING AND STORAGE
General handling Avoid contact with eyes, skin and clothing. Avoid breathing vapor or mist.
Keep in tightly sealed containers in a cool, dry, well-ventilated area away
Storage conditions
from food or containers of feed. Do not re-use containers. Avoid freezing
conditions.
10000449 - Oti-Clens庐 Pfizer Inc.
Revision date: 02/03/94, Version: 1.0.0 Page 2 of 5
SECTION 8 - EXPOSURE CONTROLS/PERSONAL PROTECTION
Exposure limits
Compound Issuer Type OEL
Propylene Glycol AIHA-WEEL TWA-8 Hr 50 ppm (total)
AIHA-WEEL TWA-8 Hr 10 mg/m鲁 (aerosol)
UK OES TWA-8 Hr 150 ppm (vapor and particulates)
Good general ventilation should be sufficient to control airborne levels.
Ventilation
Respirators are not required for normal use of this material.
Respiratory protection
Wear safety glasses if eye contact is possible.
Eye protection
Wear clothing with long sleeves to avoid skin contact. Wash hands and
Skin protection
arms thoroughly after handling this material. Clean up spills immediately.
Wear impervious gloves to avoid routine skin contact.
Hand protection
SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
Liquid
Physical form
Colorless
Color
Clear
Clarity
Menthol/citronella
Odor
Mixture
Molecular weight
Mixture
Molecular formula
2.3 (Active ingredients)
pH
No data available
Boiling point
No data available
Melting point
No data available
Density
No data available
Vapor pressure
Components are soluble in water
Water solubility
No data available
Solvent solubility
SECTION 10 - STABILITY AND REACTIVITY
Stable
Reactivity
Avoid direct sunlight, conditions that might generate heat and
Conditions to avoid
temperatures below 0 degrees C.
None identified
Incompatibilities
10000449 - Oti-Clens庐 Pfizer Inc.
Revision date: 02/03/94, Version: 1.0.0 Page 3 of 5
SECTION 10 - STABILITY AND REACTIVITY ... continued
None under normal conditions
Hazardous
decomposition
products
Not expected to occur
Hazardous
polymerization
SECTION 11 - TOXICOLOGY INFORMATION
Acute toxicity
Compound Type Route Species Dosage
Malic acid LD50 Oral Mouse 1600-3200
mg/kg
LD50 Oral Rat >3200 mg/kg
LD50 IP Mouse 50-100 mg/kg
LD50 IP Rat 100-200 mg/kg
Irritation Ocular Rabbit severe
Irritation Dermal Rabbit moderate
Benzoic Acid LD50 Oral Rat 2350 mg/kg
Salicylic Acid LC50/1H Inhalation Rat > 900 mg/m鲁
LD50 Oral Rat 891 mg/kg
LD50 Oral Mouse 480 mg/kg
Propylene Glycol LD50 Oral Rat 20,000 mg/kg
LD50 Oral Mouse 22,000 mg/kg
LD50 Dermal Rabbit 20,800 mg/kg
LD50 Oral Mouse 30,000 mg/kg
LD50 Oral Rabbit 18,000 mg/kg
LD50 Oral Rat >24,000 mg/kg
Eye Not determined for this mixture. Irritation might occur based on the effects
of individual components.
Skin Not determined for this mixture. Irritation might occur based on the effects
of individual components.
Not determined for this mixture. However, adverse effects from inhalation
Inhalation
would not be expected based on effects of individual components.
Not determined for this mixture. The calculated oral LD50 is greater than
Ingestion
2000 mg/kg in rats, based on toxicities of individual components.
Not determined for this mixture.
Mutagenicity
Not determined for this mixture.
Subchronic effects
Not determined for this mixture.
Chronic effects/
carcinogenicity
None of the components of this formulation is listed as a carcinogen by
Carcinogen status
IARC, NTP or OSHA.
10000449 - Oti-Clens庐 Pfizer Inc.
Revision date: 02/03/94, Version: 1.0.0 Page 4 of 5
SECTION 11 - TOXICOLOGY INFORMATION ... continued
Not determined for this mixture.
Reproductive effects
Not determined for this mixture.
Teratogenicity
Individuals with impaired renal function or skin disorders might be
At increased risk from
sensitive to the effects of one component, propylene glycol.
exposure
SECTION 12 - ECOLOGICAL INFORMATION
The environmental characteristics of this mixture have not been fully
Environmental overview
evaluated. Releases to the environment should be avoided.
SECTION 13 - DISPOSAL INFORMATION
Collect for recycling or recovery, if possible. Observe all local and
Disposal procedure
national regulations when disposing of this mixture.
SECTION 14 - TRANSPORTATION INFORMATION
Not regulated for transport under USDOT, EUADR, IATA, or IMDG
General shipping
regulations.
instructions
SECTION 15 - REGULATORY INFORMATION
Not classified
EU Classification
This product has been classified in accordance with the hazard criteria of
Canadian WHMIS
the CPR and the MSDS contains all of the information required by the
CPR.
SECTION 16 - OTHER
Disclaimer Pfizer Inc believes that the information contained in this Material
Safety Data Sheet is accurate, and while it is provided in good faith, it
is without a warranty of any kind, expressed or implied.
10000449 - Oti-Clens庐 Pfizer Inc.
Revision date: 02/03/94, Version: 1.0.0 Page 5 of 5
|